Aerocrine: Interim report January – March 2012

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News:

Aerocrine (STO:AEROB):

January – March 2012

- Global Net sales grew by 76% to SEK 39.0m (22.2). Adjusted for currency fluctuations, net sales rose by 72%

- The worldwide number of NIOX MINO® repeat tests sold increased by a total of 47% and for clinical use in the US by 112%

Back to news